Video Experimental Relacionado
Updated: Jul 21, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Hepatitis B viral es el virus de la hepatitis B
Ching Lung Lai1, Vlad Ratziu, Man-Fung Yuen
1Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China. hrmelcl@hkucc.hku.hk
Lancet (London, England)
|December 31, 2003
Resumen
La infección por el virus de la hepatitis B afecta a más de 400 millones de personas en todo el mundo, lo que lleva al cáncer de hígado y otras afecciones graves. Los avances en vacunas y tratamientos ofrecen esperanza para el manejo de la infección crónica por hepatitis B (VHB).
Área de la Ciencia:
- Hepatología Hepatología.
- Virología Virología.
- Oncología Oncología.
Sus antecedentes:
- La infección crónica por el virus de la hepatitis B (VHB) afecta a más de 400 millones de personas en todo el mundo.
- El VHB es una de las principales causas de cáncer de hígado, hemorragia gastrointestinal y ascitis.
- Se ha logrado un progreso significativo en el diagnóstico y tratamiento del VHB.
Objetivo del estudio:
- Revisar los avances recientes en el diagnóstico y tratamiento de la hepatitis B.
- Para discutir el papel de la virología molecular en la comprensión de los mutantes del VHB.
- Para explorar la importancia clínica de la baja carga viral y los genotipos en la infección por el VHB.
Principales métodos:
- Revisión de la literatura actual sobre el diagnóstico y tratamiento de la hepatitis B.
- Análisis de los avances en la virología molecular, incluidas las mutaciones del VHB.
- Investigación sobre el significado clínico de la carga viral y los genotipos.
Principales resultados:
- La vacuna contra la hepatitis B reduce efectivamente la incidencia del cáncer de hígado.
- La virología molecular ha avanzado en la comprensión de los mutantes del VHB que ocurren naturalmente y los inducidos por el tratamiento.
- Las monoterapias actuales (interferón, lamivudina, adefovir dipivoxil) rara vez erradican el VHB, pero reducen la replicación viral, la necroinflamación y la progresión de la fibrosis.
- Los análogos de nucleósidos como la lamivudina muestran potencial para revertir la cirrosis hepática.
Conclusiones:
- La vacunación contra la hepatitis B es crucial para prevenir el cáncer de hígado.
- La investigación en curso en virología molecular es clave para comprender y combatir el VHB.
- Si bien no es curativo, las terapias actuales mejoran significativamente los resultados para los pacientes con VHB crónico, con potencial para la reversión del daño hepático.
Videos de Conceptos Relacionados
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...